These effects, along with a preceding report demonstrating that a small-molecule ACKR3 agonist CCX771 displays anxiolytic-like conduct in mice,2 support the principle of targeting ACKR3 as a novel method to modulate the opioid program, which could open up new therapeutic avenues for opioid-related disorders. Submitting this review ensures that https://franciso612aja6.humor-blog.com/profile